Literature DB >> 26522829

Low-level resistance and clonal diversity of Pseudomonas aeruginosa among chronically colonized cystic fibrosis patients.

Alex Guerra Ferreira1, Robson Souza Leão1, Ana Paula D'alincourt Carvalho-Assef2, Érica Aparecida dos Santos Ribeiro da Silva3, Monica de Cássia Firmida3, Tania Wrobel Folescu4, Vilma Almeida Paixão5, Maria Angélica Santana5, Fernando Antonio de Abreu e Silva6, Afonso Luís Barth7, Elizabeth Andrade Marques1.   

Abstract

A prospective study was conducted in Brazil to evaluate antimicrobial resistance patterns and molecular epidemiology of Pseudomonas aeruginosa isolates from cystic fibrosis (CF) patients with chronic lung infection. All isolates were obtained between May 2009 and June 2010 from 75 patients seen in four reference centers in Brazil: HCPA (20 patients) and HEOM (15 patients), located in southern and northeastern Brazil, respectively; IFF (20 patients) and HUPE (20 patients), both in southwestern Brazil. Antimicrobial susceptibility testing, PCR for detection of carpapenemases, and pulsed-field gel electrophoresis (PFGE) were performed in 274 isolates. A total of 224 PFGE types were identified and no clones were found circulating among the centers or within the same center. Despite the chronic infection, most patients were colonized by intermittent clones. Only three patients (4%) maintained the same clone during the study. The resistance rates were lower than 30% for the majority of antimicrobials tested in all centers and only 17% of isolates were multiresistant. Isolates (n = 54) with reduced susceptibility to imipenem and/or meropenem presented negative results for blaSPM-1, blaIMP-1, blaVIM , and blaKPC genes. Our results indicate an unexpected low level of antimicrobial resistance and a high genotypic diversity among P. aeruginosa from Brazilian chronic CF patients.
© 2015 APMIS. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Cystic fibrosis; Pseudomonas aeruginosa; antimicrobial resistance; molecular epidemiology

Mesh:

Substances:

Year:  2015        PMID: 26522829     DOI: 10.1111/apm.12463

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  4 in total

Review 1.  Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis.

Authors:  Michael D Parkins; Ranjani Somayaji; Valerie J Waters
Journal:  Clin Microbiol Rev       Date:  2018-08-29       Impact factor: 26.132

2.  Antimicrobial Susceptibility of Pseudomonas aeruginosa Isolated from Cystic Fibrosis Patients in Northern Europe.

Authors:  Muhammad-Hariri Mustafa; Hussein Chalhoub; Olivier Denis; Ariane Deplano; Anne Vergison; Hector Rodriguez-Villalobos; Michael M Tunney; J Stuart Elborn; Barbara C Kahl; Hamidou Traore; Francis Vanderbist; Paul M Tulkens; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

3.  Interplay of OpdP Porin and Chromosomal Carbapenemases in the Determination of Carbapenem Resistance/Susceptibility in Pseudomonas aeruginosa.

Authors:  Jad Atrissi; Annalisa Milan; Raffaela Bressan; Marianna Lucafò; Vincenzo Petix; Marina Busetti; Lucilla Dolzani; Cristina Lagatolla
Journal:  Microbiol Spectr       Date:  2021-09-29

4.  Dendrimer-based selective autophagy-induction rescues ΔF508-CFTR and inhibits Pseudomonas aeruginosa infection in cystic fibrosis.

Authors:  Scott Mackenzie Brockman; Manish Bodas; David Silverberg; Ajit Sharma; Neeraj Vij
Journal:  PLoS One       Date:  2017-09-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.